DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

RegenLab France Receives Prestigious EU-EIB Innovation Champion Award

2024-06-13 11:26:00

PARIS-SACLAY, France--()--RegenLab, a pioneering biotechnology company specializing in the research, development, and manufacturing of patented cell and tissue engineering medical devices, has been honored with the “Innovation Champion Award” by the European Investment Bank (EIB) at the European Convention Center in Luxembourg.

This prestigious award recognizes RegenLab France’s commitment to “reshoring” by establishing a state-of-the-art biotechnology factory in Paris-Saclay and its innovation, the REGENMATRIX® PRP-HA. This next-generation product combines Platelet-Rich Plasma (PRP) with cross-linked Hyaluronic Acid (HA) in a single tube, designed specifically to address the needs of patients with advanced grade III-IV knee osteoarthritis. Currently, a clinical study is underway in 16 university hospitals across France to demonstrate the effectiveness and safety of this groundbreaking treatment.

We are honored and delighted to receive this award from the European Investment Bank,” said Mr. Antoine Turzi, Founder & CEO of RegenLab France. “This recognition celebrates the successful completion of our French factory and our ongoing R&D efforts. Our goal is to innovate in cell therapies and enhance the well-being of patients, while supporting industry reshoring in France.”

RegenLab’s achievement not only highlights its dedication to advancing medical science but also underscores the pivotal role of the EIB in promoting innovation, its sustainable growth across Europe and its competitiveness worldwide.

About RegenLab

Based in Paris Saclay, RegenLab France is a company specialized in the R&D and manufacturing of tissue engineering medical devices supported by 100 patents. The Company’s solutions are commercialized in more than 90 countries. The core technology of the Company is manufacturing of medical devices for autologous platelet-rich plasma (PRP) & Tissue Engineering, consisting in reinjecting the patient’s own cells and platelets into tissue lesions in order to stimulate tissue healing. The RegenKit, CellularMatrix… brands,  have been CE marked EU-MDR 2017/745 and approved by US-FDA, CFDA & worldwide regulatory agencies;  they are routinely used for the treatment of a wide variety of indications including joint osteoarthritis, tendinopathies, woman health and dermo-aesthetics. The Company’s medical devices are also manufactured in the factory of Le Mont-sur-Lausanne (Switzerland) & New York (USA).

Contacts

RegenLab France SAS | +33 1 77 44 60 60 | info@regenlab.com
Antoine Turzi | C.E.O.
Hubert de Pombriant I General Manager
Jean-Marc Biscarrat | Chief Financial Officer

RegenLab France receives prestigious EU-EIB Innovation Champion Award. Antoine Turzi, CEO and Founder of RegenLab, pictured between two officials of the European Investment Bank. (Photo: Business Wire)

Link

Interfax Business Wire

2024-07-24
17:38:00
People, Passion, Planet: Mary Kay Releases 2024 Sustainability Report
16:59:00
DCO Calls for Urgent Discussions with Member States, Digital Experts to Address Recent Global IT Outage’s Implications
16:57:00
LambdaTest Integrates with Netlify to Enhance Developer Workflows
16:55:00
Laserfiche Global Headquarters Achieves LEED Silver Certification
16:52:00
CSC and Palo Alto Networks Join Forces to Fortify Domain Security for Cortex XSOAR, XSIAM, and XPANSE Users and CSC Domain Registrar Clients
16:45:00
SLB to Accelerate Co-Development of AI-Driven Digital Platform for Aker BP
16:42:00
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
14:48:00
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
14:43:00
NIPPON KINZOKU’s Cold Profile Rolled Products Are Named "Fine Profile” to Strengthen Sales Expansion
14:40:00
Andersen Global Broadens Footprint in Czech Republic
14:33:00
Lifezone Metals Produces First-Ever Nickel, Copper and Cobalt from Kabanga Nickel Project
14:29:00
Mavenir Moves in on Market Leader Status in New Omdia Core Vendors Report
13:18:00
Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
10:19:00
Corpay Cross-Border Named the Official B2B FX Partner for AEG Presents UK in Europe
10:13:00
COOLMAX® EcoMade Fiber Makes Summer Games Debut in Paris
2024-07-23
16:56:00
Faraday Adds Video Interface IP to Support All Advanced Planar Nodes on UMC Platform
16:45:00
Corona Cero Brings Same Seats as from Olympic Games Venues to Iconic Sunset Destinations Around the World
16:41:00
Join China Hi-Tech Fair 2024, Where Innovation Meets Global Opportunity
11:31:00
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
11:28:00
MSCI Strengthens Private Markets Leadership With Launch of 130 Indexes
Back to Top